Year: 2024

[ad_1] Fulcrum rises after BofA upgrades rating on chance of FSHD study success [ad_2] Source: Seekingalpha

[ad_1] zimmytws Shares of CVS Health (NYSE:CVS) and Humana (NYSE:HUM) moved decrease Monday after the White House introduced new health insurance coverage necessities and Leerink warned…

[ad_1] J&J Rybrevant/Lazcluze study shows superiority over Tagrisso [ad_2] Source: Seekingalpha

[ad_1] Summit a ‘top pick’ at Citi after ‘unprecedented’ trial outcomes, bull rally [ad_2] Source: Seekingalpha

[ad_1] Xencor stock rallies 24% amid drug development updates [ad_2] Source: Seekingalpha

[ad_1] Relay Therapeutics announces proposed public offering of common stock [ad_2] Source: Seekingalpha

[ad_1] Immunovant stock falls 8% amid Graves’ disease program update [ad_2] Source: Seekingalpha

[ad_1] IvelinRadkov AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) stated {that a} Phase 3 examine of their antibody drug conjugate, or ADC, datopotamab deruxtecan didn’t present…

[ad_1] UniDoc qualifies to partner with U.S. telecommunications companies [ad_2] Source: Seekingalpha

[ad_1] Rockwell Medical enters into product purchase agreement [ad_2] Source: Seekingalpha